Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000348002 | SCV000382451 | uncertain significance | Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000400699 | SCV000382452 | uncertain significance | Porencephalic cyst | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV002248573 | SCV000382453 | uncertain significance | Brain small vessel disease 1 with or without ocular anomalies | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000880929 | SCV001024059 | benign | not provided | 2024-12-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000880929 | SCV001149086 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | COL4A1: BP4, BS2 |
Gene |
RCV000880929 | SCV002504341 | uncertain significance | not provided | 2024-10-21 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Occurs in the triple helical domain at the X position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the X position is not a common mechanism of disease; In silico analysis indicates that this missense variant does not alter protein structure/function |
Ambry Genetics | RCV004975431 | SCV005568940 | likely benign | Inborn genetic diseases | 2024-10-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |